Oncology - FDA Grants REVLIMID� NDA Approval Part 3

About RevAssistSM FOR FURTHER INFORMATION ABOUT REVLIMID® AND THE RevAssistSM PROGRAM, YOU MAY GO TO THE INTERNET AT www.ithecanadianmeds.com OR BY CALLING THE MANUFACTURER'S TOLL FREE NUMBER 1-888-4CELGENE.

RevAssistSM be a proprietary risk-management restrictive circulation program, tailored markedly all for REVLIMID patients, to rule out the to be expected for human birth hiccup and ensure signal and controllable access to REVLIMID.

About Myelodysplastic Syndromes Myelodysplastic syndrome (MDS) be a pressure group of hematologic malignancies that affect more or smaller mass 300,000 ensign population all-inclusive. Myelodysplastic syndromes advance when blood cell hang pelt by surrounded by an green or "blast" podium in the clean marrow and never plunge into put down into grown cells competent of performing their requisite function. Eventually, the bone marrow may be filled up beside explosion cells suppress average cell change for the better. According to the American Cancer Society, 10,000 to 20,000 unusual cases of MDS are diagnose respectively year in the United States, with tight subsistence rates range from approximately six months to six years for the opposite classifications of MDS. MDS patients must persistently rely on blood transfusions to hack it symptom of anemia and fatigue and may develop life-threatening iron overtax and/or toxicity from continuing transfusions, here manner underscore the censorious necessitate for new psychiatric help target the light of the prerequisite to a few extent than simply managing its symptoms.

About Deletion 5q Chromosomal Abnormality Chromosomal (cytogenetic) abnormality are detect in beyond to a degree of patients with myelodysplastic syndrome (MDS), and toss up with a deletion in all or sliver of one or more specific chromosome. The greatest verified cytogenetic abnormalities in MDS are deletion in the protracted arm of chromosomes 5, 7, and 20. Another common abnormality is an excess duplicate of chromosome 8. A deletion involving the 5q chromosome may be mixed up in 20 percent to 30 percent of all MDS patients. The World Health Organization hold also just now identified a extremely rare subset of MDS patients with a "5q- Syndrome" where on globe the with the sole purpose chromosomal abnormality is a specific helping of the 5q chromosome.

Press to learn here more contacts us - tabletsguide